You are viewing: Japan Bioresorbable Polymers Market analysis
Part of: Bioresorbable Polymers Market (Global)

The Japan Bioresorbable Polymers Market was valued at $18.7 Million in 2024 and projected to reach to $32.7 Million by 2029, representing a compound annual growth rate of 11.9%. Japan's bioresorbable polymers market is positioned for sustained expansion, driven by the country's aging population and advanced healthcare infrastructure.

Japan Bioresorbable Polymers Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Japan Bioresorbable Polymers Market Trends and Insights

  • Japan's advanced healthcare infrastructure and strong pharmaceutical sector are driving adoption of bioresorbable polymers in medical devices, surgical implants, and drug delivery systems.
  • The country's aging population and emphasis on minimally invasive procedures further accelerate demand for innovative bioresorbable solutions. Japan leads the Asia Pacific region in bioresorbable polymer innovation, supported by significant R&D investments from domestic manufacturers and healthcare institutions.
  • Japan's regulatory environment, governed by the PMDA (Pharmaceuticals and Medical Devices Agency), facilitates rapid commercialization of bioresorbable polymer-based products.
  • The 11.9% CAGR through 2029 reflects Japan's commitment to advanced biomaterials and regenerative medicine applications. Japan's market growth is underpinned by increasing clinical adoption in orthopedic, cardiovascular, and dental applications.
  • Japan's strategic positioning as a global medical device hub ensures sustained investment in bioresorbable polymer technologies, positioning the country as a key growth engine within the Asia Pacific bioresorbable polymers market..

Key Market Statistics

  • CAGR (2024-2029) 11.9% CAGR
  • Market Size, 2024 ~USD 18.7 Million
  • Forecast, 2029 ~USD 32.7 Million
  • Country Japan

Japan Bioresorbable Polymers Market Overview

Market Valuation Growth :

Japan's bioresorbable polymers market is valued at $18.7 million in 2024, with a projected CAGR of 11.9% through 2029, reaching $32.7 million by forecast end.

Healthcare Infrastructure Advantage :

Japan's advanced healthcare system and robust pharmaceutical sector provide strong adoption drivers for bioresorbable polymers in medical devices and surgical implants.

Aging Population Dynamics :

Japan's rapidly aging demographic creates sustained demand for innovative medical solutions, positioning bioresorbable polymers as critical for next-generation surgical and implant applications.

Minimally Invasive Focus :

Strong emphasis on minimally invasive procedures in Japanese healthcare drives adoption of bioresorbable polymers in drug delivery systems and surgical applications.

Japan Bioresorbable Polymers Market Dynamics

  • The 11.9% CAGR reflects growing adoption across medical devices, surgical implants, and drug delivery systems.
  • Japanese pharmaceutical companies and medical device manufacturers are increasingly investing in bioresorbable polymer technologies to meet regulatory standards and patient demands for safer, more effective solutions. The market outlook remains positive as Japan continues to prioritize minimally invasive surgical techniques and innovative implant materials.
  • Government support for healthcare innovation, combined with strong R&D capabilities in the pharmaceutical sector, will further accelerate market penetration.
  • By 2029, bioresorbable polymers are expected to capture a larger share of Japan's medical device market, particularly in orthopedic, cardiovascular, and dental applications..

Related Ecosystem

Green Bio Chemicals

Top Technologies
  • Animal-Based Sealants
  • Bacterial Fermentation
  • Corrosion Inhibitors
  • Hydrogen Peroxide
  • Nitrile Butadiene Rubber (NBR)
Top Companies
  • Basf se
  • Evonik industries ag
  • Solvay sa
  • AZELIS HOLDINGS SA
  • CARGILL, INCORPORATED

    Resins And Polymers

    Top Technologies
    • Polycarbonate
    • Acrylonitrile Butadiene Styrene (ABS)
    • Epoxy Resin
    • Light Commercial Vehicles (LCVs)
    • Polypropylene (PP)
    Top Companies
    • Basf se
    • DOW CHEMICAL COMPANY
    • Solvay sa
    • Saudi arabia basic industries corporation (sabic)
    • DuPont de Nemours, Inc.

      Key Takeaways

      • Japan's bioresorbable polymers market is valued at $18.7 million in 2024 and is forecast to reach $32.7 million by 2029, representing a 11.9% CAGR.
      • Japan's advanced healthcare infrastructure and PMDA regulatory framework accelerate commercialization of bioresorbable polymer-based medical devices.
      • Japan's aging population and preference for minimally invasive surgical procedures drive strong demand for bioresorbable implants and drug delivery systems.
      • Japan's position as a global medical device hub and significant R&D investments position the country as a key growth driver in the Asia Pacific bioresorbable polymers market.

      Bioresorbable Polymers Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment PLGA (Type)
      Forecast Period 2024-2029
      Growth Rate CAGR of 11.6% from 2024 to 2029
      Largest Segment ORTHOPEDIC DEVICES (Application)
      Market Size Base Year (Billions) ~USD 0.5 (2024)
      Revenue Forecast (Billions) ~USD 0.87 (2029)
      Segments Covered Type, Application

      Japan Bioresorbable Polymers Market Report Segmentation

      2 segment dimensions are covered across the global market.

      By Type

      • Other Types
      • Pcl
      • Pga
      • Pla
      • Plga
      • -Pdlla
      • -Plla

      By Application

      • Drug Delivery
      • Hip
      • Knee
      • Oral
      • Orthopedic Devices
      • Other Applications
      • Other Drug Delivery Applications
      • Other Orthopedic Device Applications
      • Parenteral
      • Spine
      • Sports Injury
      • Trauma

      JAPAN: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023–2029

      Segment2023202420252026202720282029CAGR (%)
      DRUG DELIVERY6.517.228.059.0310.1811.513.0112.5
      ORTHOPEDIC DEVICES8.99.7610.7811.9713.3614.9416.7311.4
      OTHER APPLICATIONS1.531.691.872.092.352.642.9711.9
      TOTAL16.9418.6720.7123.0925.8929.0832.7211.9

      Target Audience

      • Medical Device Manufacturers : Japanese and international medical device companies need Japan-specific market data to develop localized product strategies, identify growth segments, and plan manufacturing investments.
      • Pharmaceutical Companies : Pharma firms require detailed insights into Japan's drug delivery system market and bioresorbable polymer adoption rates to optimize R&D pipelines and commercialization timelines.
      • Material Science & Polymer Suppliers : Raw material suppliers and polymer manufacturers need Japan market intelligence to identify customer demand, pricing trends, and supply chain opportunities in the bioresorbable segment.
      • Healthcare Investors & PE Firms : Investment professionals evaluating Japanese healthcare companies require market sizing, growth projections, and competitive positioning data for due diligence and portfolio decisions.
      • Healthcare Policy & Regulatory Bodies : Government agencies and regulatory organizations need market data to inform healthcare policy, reimbursement strategies, and innovation incentives for bioresorbable polymer technologies.

      Reasons to Buy this Report

      • Japan-Specific Market Sizing : Access precise valuation data for Japan's bioresorbable polymers market with verified 2024 baseline ($18.7M) and 2029 forecasts ($32.7M), enabling accurate budget allocation and ROI projections.
      • Competitive Landscape Intelligence : Understand Japan's unique competitive dynamics, local manufacturer strategies, and market consolidation trends specific to the Japanese bioresorbable polymers sector.
      • Regulatory & Compliance Insights : Gain detailed knowledge of Japan's PMDA approval pathways, regulatory requirements, and compliance standards for bioresorbable polymers in medical devices and pharmaceuticals.
      • Application-Specific Demand Analysis : Identify high-growth segments within Japan including orthopedic implants, cardiovascular devices, and dental applications with segment-level forecasts and adoption rates.
      • Strategic Partnership Opportunities : Discover key Japanese pharmaceutical companies, medical device manufacturers, and research institutions actively developing bioresorbable polymer solutions for market expansion.

      Frequently asked questions

      What is the current market size of bioresorbable polymers in Japan?

      Japan's bioresorbable polymers market was valued at $18.7 million in 2024 and is projected to grow to $32.7 million by 2029.

      What is the expected growth rate for Japan's bioresorbable polymers market?

      Japan's bioresorbable polymers market is expected to grow at a compound annual growth rate (CAGR) of 11.9% from 2024 to 2029.

      Which applications drive bioresorbable polymer demand in Japan?

      Japan's demand for bioresorbable polymers is driven by orthopedic implants, cardiovascular devices, dental applications, and drug delivery systems, supported by the country's preference for minimally invasive procedures.

      How does Japan's regulatory environment support bioresorbable polymer adoption?

      Japan's PMDA (Pharmaceuticals and Medical Devices Agency) provides a streamlined regulatory pathway that facilitates rapid commercialization of bioresorbable polymer-based medical devices.

      Why is Japan a key market for bioresorbable polymers in Asia Pacific?

      Japan's advanced healthcare infrastructure, aging population, strong R&D ecosystem, and position as a global medical device hub make it a leading market for bioresorbable polymer innovation and adoption in Asia Pacific.

      RESEARCH METHODOLOGY

      The study involved four major activities in estimating the market size for bioresorbable polymers market. Exhaustive secondary research was done to collect information on the market, the peer market, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, the market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

      Secondary Research

      Secondary sources used in this study included annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles from recognized authors; and gold standard & silver standard websites such as Factiva, ICIS, Bloomberg, and others. The findings of this study were verified through primary research by conducting extensive interviews with key officials such as CEOs, VPs, directors, and other executives. The breakdown of profiles of the primary interviewees is illustrated in the figure below:

      Primary Research

      The bioresorbable polymers market comprises several stakeholders, such as raw material suppliers, end-product manufacturers, and regulatory organizations in the supply chain. The demand side of this market is characterized from key opinion leaders in various applications for the bioresorbable polymers market. The supply side is characterized by advancements in technology and diverse application industries. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

      The following is a breakdown of the primary respondents:

      Note: Tier 1, Tier 2, and Tier 3 companies are classified based on their market revenue in 2022/ 2023, available in the public domain, product portfolios, and geographical presence.

      Other designations include consultants and sales, marketing, and procurement managers.

      To know about the assumptions considered for the study, download the pdf brochure

      COMPANY NAME DESIGNATION
      Evonik Industries AG Sales Manager
      Ashland Global Holdings Inc. R&D Manager
      KLS Martin Group Global R&D Head
      DSM Biomedical Business Development Manager
      Poly-Med Incorporated Regional Sales Manager

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the bioresorbable polymers market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      • The key players in the industry have been identified through extensive secondary research.
      • The supply chain of the industry has been determined through primary and secondary research.
      • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
      • All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.

      Data Triangulation

      After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the bioresorbable polymers industry.

      Market Definition

      The bioresorbable polymers are the type of polymers. They are designed to naturally degrade and be absorbed within biological environments. These polymers are utilized in medical and healthcare sectors, where they are used to manufacture orthopedic devices and drug delivery systems. The demand of bioresorbable polymers influenced by the innovation in medical devices and the need for the eco-friendly alternatives to the permanent implants. The key components of the bioresorbable polymers are PLA, PGA, PLGA, and PCL.

      Stakeholders

      • Bioresorbable polymers manufacturers
      • Bioresorbable polymers suppliers
      • Raw material suppliers
      • Application sector companies
      • Government bodies

      Report Objectives

      • To define, describe, and forecast the bioresorbable polymers market in terms of value and volume
      • To provide detailed information regarding the drivers, opportunities, restraints, and challenges influencing market growth
      • To estimate and forecast the market size by type, application, and region
      • To forecast the size of the market for five main regions: Asia Pacific, Europe, North America, South America, and the Middle East & Africa, along with their key countries
      • To strategically analyze micromarkets1 with respect to their growth trends, prospects, and contribution to the overall market
      • To analyze opportunities in the market for stakeholders and provide a competitive landscape for market leaders
      • To analyze competitive developments, such as deals and expansions, in the market
      • To strategically profile key players and comprehensively analyze their growth strategies

      Get the Full Bioresorbable Polymers Market Report

      Full forecast, segment splits, and company analysis for all Bioresorbable Polymers Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status